surpass tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial Overview of the SURPASS clinical

Both medications carry warnings about thyroid tumors based on animal studies

Innovent Biologics' dual GLP-1/glucagon receptor agonist, mazdutide, outperformed Novo Nordisk's semaglutide in a late-stage, head-to-head clinical trial among overweight individuals with type 2 diabetes, the company said

Stability-Induced Immunogenic Risk Stability studies are particularly important for immunogenicity evaluation, as certain impurities may not be present at release but can emerge over shelf life

parenting Miles Apart, But Planning A Family Together: The Fertility Reality Of Long-Distance Marriages In India Home Nutrition These Foods Can Mimic The Effects Of Ozempic